ORGANIZATION

• Sales Rose Only Slightly, but Drug Wholesalers Still Improved Profit Rates in FY2018: JPWA
  August 16, 2019

• Experts Talk over Biosimilar Challenges, Chide Unstable Supplies and Indication Gaps
  July 19, 2019

• OTC Groups Call for Enhancing Self-Medication Tax Break, Submit Request
  July 19, 2019

• Towards 2020 Reform, JPMA Wants Its Three-Pronged Proposal to Resonate with Public
  July 17, 2019

• FPMAJ Asks Member Drug Makers to Conduct Self-Inspections to Ensure Stable Supplies
  July 11, 2019

• Generic Association Aims to Contribute to Pre-Symptomatic and Preventive Care: New Industry Vision
  July 9, 2019

• JPMA Pushing Teleworking for Member Companies
  July 5, 2019

• Generic Use Rate at 74.0% in FY2018: JGA
  July 1, 2019

• Govt’s 2019 Honebuto Policy Generally in Line with JPMA Views: President
  June 28, 2019

• Revisit Comparator Selection Criteria for New Drug Pricing: JPMA
  June 28, 2019

• OTC Group Unveils Reform Requests for Self-Medication Tax Break
  June 25, 2019

• Further Pricing Discussions Needed for Pricey Products beyond Kymriah: JMA Chief
  June 25, 2019

• Health Insurance Coverage Necessary for Risk Reducing Treatments for BRCA Positive Patients: Cancer Bodies
  June 21, 2019

• Japan Doctors’ Lobby Braced for Tough Social Security Debate after Election
  June 20, 2019

• Generic Share Hits Plateau after Reaching 70%: FPMAJ Pharmacy Survey
  June 17, 2019

• Don’t Expand Comparator PMP Removal Rule, Set Deduction Limit for Method II: FPMAJ
  June 17, 2019

• Discuss Cost Effectiveness Assessment, Disclosure Ratios Separately: FPMAJ
  June 17, 2019

• FPMAJ Calls for Post-Launch Premiums for Add’l Indications, Evidence
  June 17, 2019

• Fix Price Maintenance Premium to Make It Fit Its Concept, Revisit Product/Company Criteria: FPMAJ
  June 17, 2019

• JPMA Nudges PMDA to Increase Int’l Staffers, Drive Harmonization in Asia
  June 12, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• …
• Next ›
• 最終 »